Universidad de Cantabria-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2018

  1. Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders

    Biochemical Pharmacology, Vol. 157, pp. 258-265

2010

  1. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms

    Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434

2007

  1. CB1 knockout mice display impaired functionality of 5-HT 1A and 5-HT2A/C receptors

    Journal of Neurochemistry, Vol. 103, Núm. 5, pp. 2111-2120

2004

  1. A single in-vivo exposure to Δ9THC blocks endocannabinoid-mediated synaptic plasticity

    Nature Neuroscience, Vol. 7, Núm. 6, pp. 585-586

  2. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain

    Neuropharmacology, Vol. 46, Núm. 5, pp. 716-726

2003

  1. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain

    European Journal of Neuroscience, Vol. 17, Núm. 9, pp. 1747-1754

2002

  1. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain

    European Journal of Pharmacology, Vol. 443, Núm. 1-3, pp. 43-46